UPDATE: Citigroup Downgrades Masimo Corporation to Sell

Citigroup lowers its rating on Masimo Corporation MASI to Sell from Neutral and lowers its price target to $20 from $21 on utilization challenges. Citigroup says, "2012 is unlikely to get easier for MASI after a tough 2011 where we saw further margin erosion and limited technology adoption among hospital customers. Software updates and the Pronto-7 re-launch also won't fix larger headwinds tied to reprocessed sensors and difficult admission trends for the core pulse-oximetry business." MASI closed at $21.81 a share on Thursday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorPrice TargetReiterationIntraday UpdateAnalyst RatingsCitigroupHealth CareHealth Care Equipment
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!